Yeqian Huang1, Nayef A Alzahrani2, Terence C Chua3, Winston Liauw4, David L Morris5. 1. Department of Surgery, University of New South Wales, St George Hospital, New South Wales, Australia. 2. Department of Surgery, University of New South Wales, St George Hospital, New South Wales, Australia; College of Medicine, Imam Muhammad ibn Saud Islamic University, Riyadh, Saudi Arabia. 3. Department of Surgery, Ryde Hospital, North Shore Ryde Health Service, New South Wales, Australia. 4. Department of Medical Oncology, University of New South Wales, St George Hospital, Sydney, New South Wales, Australia. 5. Department of Surgery, University of New South Wales, St George Hospital, New South Wales, Australia. Electronic address: david.morris@unsw.edu.au.
Abstract
INTRODUCTION: Peritoneal cancer index (PCI) has been suggested to be the most important prognostic factors for the outcomes in colorectal peritoneal carcinomatosis (CRPC). METHODS: This was a retrospective study of prospectively collected data of 168 consecutive patients with CRPC following cytoreductive surgery (CRS) and perioperative intraperitoneal chemotherapy (PIC). Patients were divided into five groups according to their PCI. RESULTS: Hospital mortality was 0%. Patients in low PCI groups had a significantly lower major morbidity rate, shorter intensive care unit and high dependency unit stay and higher overall survival (p=0.017, 0.001, 0.046, p<0.001 respectively). CONCLUSION: Combined CRS with PIC can be safely performed to provide encouraging survival benefits for patients with CRPC. Our findings suggest that this approach is particularly beneficial for patients with low volume of disease. Early referral to specialist centre for evaluation is warranted for better survival outcomes.
INTRODUCTION: Peritoneal cancer index (PCI) has been suggested to be the most important prognostic factors for the outcomes in colorectal peritoneal carcinomatosis (CRPC). METHODS: This was a retrospective study of prospectively collected data of 168 consecutive patients with CRPC following cytoreductive surgery (CRS) and perioperative intraperitoneal chemotherapy (PIC). Patients were divided into five groups according to their PCI. RESULTS: Hospital mortality was 0%. Patients in low PCI groups had a significantly lower major morbidity rate, shorter intensive care unit and high dependency unit stay and higher overall survival (p=0.017, 0.001, 0.046, p<0.001 respectively). CONCLUSION: Combined CRS with PIC can be safely performed to provide encouraging survival benefits for patients with CRPC. Our findings suggest that this approach is particularly beneficial for patients with low volume of disease. Early referral to specialist centre for evaluation is warranted for better survival outcomes.
Authors: Ahmed H Mekkawy; Krishna Pillai; Samina Badar; Javed Akhter; Kevin Ke; Sarah J Valle; David L Morris Journal: Am J Cancer Res Date: 2021-05-15 Impact factor: 6.166
Authors: Antoine El Asmar; Melissa Bendavides; Michel Moreau; Alain Hendlisz; Amélie Deleporte; Maher Khalife; Vincent Donckier; Gabriel Liberale Journal: World J Surg Oncol Date: 2020-11-26 Impact factor: 2.754